Internal Medicine, Infectious Disease · New York, NY
NPI
1417098310
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
109 E.38th Street
New York, NY, 10016
Phone (212) 725-0580
Medicare paid, 2024
$51K
474 services
Medicare patients, 2024
179
Average age 74
Drug cost, 2024
$435K
836 prescriptions
Company payments, 2025
$25.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas J Zeiger was code 99214 (office e&m - established), 183 times for 89 patients. In total Douglas J Zeiger billed 474 services in 20 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 183 | 89 | $112.58 | $21K |
| 99204 Office E&M - New | Office | 94 | 94 | $148.49 | $14K |
| 99213 Office E&M - Established | Office | 34 | 24 | $80.66 | $2,742 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 31 | $36.26 | $1,124 |
| 90662 Vaccine Product | Office | 30 | 30 | $81.82 | $2,455 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 23 | 23 | $143.97 | $3,311 |
| G0009 Administration of pneumococcal vaccine | Office | 14 | 14 | $36.26 | $508 |
By year: 2022 $48K for 462 services; 2023 $41K for 389 services; 2024 $51K for 474 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas J Zeiger prescribed most often to Medicare patients was Azithromycin, with 86 prescriptions and refills. In total Douglas J Zeiger wrote 836 Medicare prescriptions that cost $435K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 86 | 86 | 84 | $268 |
| Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl | 57 | 61 | 56 | $3,705 |
| Typhim Vi Typhoid Vi Polysacch Vaccine | 50 | 50 | 49 | $5,977 |
| Vaqta Hepatitis A Virus Vaccine/Pf | 42 | 42 | 38 | $4,275 |
| Adacel Tdap Diph,pertuss(Acell),tet Vac/Pf | 35 | 35 | 35 | $2,468 |
| Pravastatin Sodium Generic | 33 | 99 | Under 11 | $364 |
| Rosuvastatin Calcium Generic | 29 | 87 | Under 11 | $313 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 24 | 24 | Under 11 | $22K |
| Isentress Raltegravir Potassium | 23 | 23 | Under 11 | $49K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 23 | 25 | Under 11 | $97K |
| Amlodipine Besylate Generic | 20 | 50 | Under 11 | $35.12 |
| Metformin Hcl Generic | 17 | 51 | Under 11 | $183 |
| Atorvastatin Calcium Generic | 15 | 45 | Under 11 | $52.82 |
| Nevirapine Generic | 14 | 24 | Under 11 | $539 |
| Abacavir Abacavir Sulfate | 14 | 24 | Under 11 | $4,029 |
Brand drugs: - claims; generic drugs: 555 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas J Zeiger $25.7 ($25.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $25.7.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $25.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.